<bill session="109" type="h" number="563" updated="2013-07-19T19:09:15-04:00">
  <state datetime="2005-02-02">REFERRED</state>
  <status>
    <introduced datetime="2005-02-02"/>
  </status>
  <introduced datetime="2005-02-02"/>
  <titles>
    <title as="introduced" type="short">Prescription Drug Affordability Act of 2005</title>
    <title as="introduced" type="official">To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate and disclose lowest possible prices for prescription drug prices for Medicare beneficiaries, and, with respect to the Federal Food, Drug, and Cosmetic Act, to provide waivers that permit such beneficiaries to import prescription drugs from Canada.</title>
  </titles>
  <sponsor id="400249"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2005-02-02">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-02-02">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2005-02-02">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2005-02-14">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2005-02-25">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Cost control"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Foreign trade and international finance"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Medical records"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>2/2/2005--Introduced.
Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to negotiate with covered drug manufacturers and disclose the lowest possible prices for prescription drugs under the new Medicare prescription drug program. Directs the Secretary, acting through the Commissioner of Food and Drugs, with respect to the importation by Medicare beneficiaries of prescription drugs from Canada, to provide waivers that permit such beneficiaries to import prescription drugs from Canada.</summary>
</bill>
